A detailed history of Old Point Trust & Financial Services N A transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Old Point Trust & Financial Services N A holds 500 shares of OCUP stock, worth $790. This represents 0.0% of its overall portfolio holdings.

Number of Shares
500
Holding current value
$790
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$1.89 - $3.27 $945 - $1,635
500 New
500 $1,000

Others Institutions Holding OCUP

About Ocuphire Pharma, Inc.


  • Ticker OCUP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,579,800
  • Market Cap $32.5M
  • Description
  • Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...
More about OCUP
Track This Portfolio

Track Old Point Trust & Financial Services N A Portfolio

Follow Old Point Trust & Financial Services N A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Point Trust & Financial Services N A, based on Form 13F filings with the SEC.

News

Stay updated on Old Point Trust & Financial Services N A with notifications on news.